Publications

Sacks NC, Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885.

Urban JD, Carakostas MC, Brusick, DJ. 2013. Steviol glycoside safety: Is the genotoxicity database sufficient? Food Chem Toxicol 51:386-390.

Racz L, Baker PA, Duckworth KL, Heline TR, Woodall BD. 2013. Environmental planning while deployed: Mission hindrance or enhancement? Joint Force Quarterly 70:30–33.

Flory J, Kanel SR, Racz L, Impellitteri CA, Rendahandi GS, Goltz MN. 2013. Influence of pH on the transport of silver nanoparticles in saturated porous media: laboratory experiments and modeling. J Nanopart Res 15(3):2–11.

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801.

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Response to Goldstein et al. J Occup Environ Med 55(11):1378.

Liu L, Aguirre SA, Hosea NA, Scott W, May JR, Burns-Naas LA, et al. 2014. Intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats. Toxicol Pathol 42(2):422–434.

Thompson CM, Gaylor DW, Tachovsky JA, Perry C, Carakostas MC, Haws LC. 2013. Development of a chronic noncancer oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. J Appl Toxicol 33(12):1395-1406.

Patterson J, Maier A, Kohrman-Vincent M, Dourson ML. 2013. Peer consultation on relationship between PAC profile and toxicity of petroleum substances. Regul Toxicol Pharmacol 67:S86–S93.

Karchapati L, Bednar KJ, Adams DE, Wu Y, Mitter RS, Jordan MB, Hinerman JM, Herr AB, Ridgway WM. 2013. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice. J Autoimmun 47:94–103.

Sterner TR, Ruark CD, Covington TR, Yu KO, Gearhart JM. 2013. A physiologically based pharmacokinetic model for theoxime TMB-4: Simulation of rodent and human data. Arch Toxicol 87:661–680.

Mitchell M, Lowe K, Fryzek J. 2012. A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies. ISRN Oncology 129713; https://doi.org/10.5402/2012/129713.

Kirman, CR, Hays, SM, Aylward, LL, Suh, M, Harris, MA, Thompson, CM, Haws, LC, Proctor, DM. 2012. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact 200(1):45-64.

John-Baptiste A, Vitsky A, Sace F, Zong Q, Ko M, Yafawi R, Liu L. 2012. Comparison of 3 kidney injury multiplex panels in rats. Inter J Toxicol 31(6):529–536.

Kopec AK, Thompson CM, Kim S, Forgacs AL, Zacharewski TR. 2012. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelium. Toxicol Appl Pharmacol 262(2):124-138.

Alexander D, Weed D, Mink P, Mitchell M. 2012. A weight-of-evidence review of colorectal cancer in pesticide applicators: The agricultural health study and other epidemiologic studies. Int Arch Occup Environ Health 85(7):715–745.

Kopec AK, Kim S, Forgacs AL, Zacharewski TR, Proctor DM, Harris MA, Haws LC, Thompson CM. 2012. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol 259(1):13-26.

Lamb DJ, Parker N, Ulrich K, Walsh R, Yeadon M, Evans SM. 2012. Characterisation of a mouse model of cigarette smoke extract-induced lung inflammation. J Pulmon Resp Med 2(3):open access, doi: 10.4172/2161-105X.1000125.

Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. 2012. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301.